Glucagon-like peptide-1 (GLP-1) receptor agonists have emerged as a effective class of drugs in the management of type 2 diabetes mellitus. These agents replicate the actions of naturally occurring GLP-1, promoting insulin secretion and inhibiting glucagon release. Recent investigations have yiel… Read More

Breaking: Lilly Partners With US Firms to Make Mounjaro, Boost Supply Eli Lilly, now the world's most valuable healthcare company by market capitalization, has seen its shares soar 62.5% this year due to high demand for their d… Read More